Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@thefinreviewer 8
@reurope_stock 8
@bulletin_en 6
@1MinuteStock 6
@bibeypost_stock 6

Recent Tweets for ESPR

AmericanBanking @AmericanBanking
Esperion Therapeutics Inc $ESPR CEO Purchases $217,400.00 in Stock https://t.co/E7m9hopaS6 #stocks
March 21st 2019, 5:03pm
reurope_stock @reurope_stock
Esperion Therapeutics $ESPR Shareholder Bb Biotech Ag Increased Stake by $4.95 Million; Wedge Capital Management L… https://t.co/CjpLT4EedC
March 21st 2019, 12:03pm
ResearchPool @ResearchPool
$ESPR #Esperion Therapeutics Inc 1 director sold: A director at Esperion Therapeutics Inc sold 15,329 shares at 44.… https://t.co/Vq5bSI06ko
March 21st 2019, 12:03pm
TranscriptDaily @TranscriptDaily
Insider Selling: Esperion Therapeutics Inc $ESPR Director Sells 15,329 Shares of Stock https://t.co/t9IHQ7amzy
March 21st 2019, 11:03am
InsiderAlertsIA @InsiderAlertsIA
$ESPR: New Insider Filing on Director NICOLE VITULLO: https://t.co/DfXIs94IeC
March 21st 2019, 11:03am
bibeypost_stock @bibeypost_stock
Esperion Therapeutics, Inc. $ESPR Can't Be More Risky. The Stock Formed a Bearish H&S Chart Pattern https://t.co/0BjR7tJycb
March 21st 2019, 10:03am
reurope_stock @reurope_stock
What Will Happen to Esperion Therapeutics, Inc. $ESPR Next? The Stock Formed a Several Months Bearish Head & Should… https://t.co/l0BGpsB3pq
March 21st 2019, 10:03am
insiderbuyings @insiderbuyings
$ESPR new insider selling: 15329 shares. https://t.co/15l3VjMBP6
March 21st 2019, 10:03am
ThisLincolnian @ThisLincolnian
Esperion Therapeutics $ESPR Trading Down 2.3% https://t.co/rhDYmzGdE1
March 20th 2019, 3:03pm
EPeeps_Bot @EPeeps_Bot
RT @EsperionInc: Team $ESPR is heading home from a productive #ACC19! We’re happy to have presented further validation of the potential pro…
March 19th 2019, 4:03pm
EsperionInc @EsperionInc
Team $ESPR is heading home from a productive #ACC19! We’re happy to have presented further validation of the potent… https://t.co/wp9JQtIHar
March 19th 2019, 3:03pm
BlogYomi @BlogYomi
Pl Capital Advisors Has Decreased Its Peoples Bancorp $PEBO Holding; Esperion Therapeutics $ESPR Sentiment Is 1 https://t.co/GwvPHHCoKm
March 19th 2019, 3:03pm
AniuStudent @AniuStudent
Yes, they do say they have no idea how $ESPR ’s cheap, oral med (without the typical statin side effects) will perf… https://t.co/TRnNFcx0iX
March 19th 2019, 12:03pm
AniuStudent @AniuStudent
Thus, to repeat - What does $ESPR have that $AMRN doesn’t? A partner (for starters). ?
March 19th 2019, 12:03pm
AniuStudent @AniuStudent
@Eminyel aka There are much larger problems that cardio pharmas have to deal with than $ESPR - w/ its established m… https://t.co/8cxOX0aPR1
March 19th 2019, 12:03pm
AmpBioResearch @AmpBioResearch
@ByJonGardner Thanks for the helpful #ACC19 update. One clarification re: $ESPR, they are not going it alone at lea… https://t.co/Bb5sNtede3
March 19th 2019, 12:03pm
AndrewHakkarai1 @AndrewHakkarai1
New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered https://t.co/Eb6mucJUg8 via @statnews $ESPR
March 19th 2019, 11:03am
Eminyel @Eminyel
Can someone explain why $ESPR is at $46...seems strange after good news?
March 19th 2019, 9:03am
biotchart @biotchart
RT @HottestStockNow: $ESPR 's Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP in Late-Stage Study https://t.co/gl1w…
March 19th 2019, 6:03am
HottestStockNow @HottestStockNow
$ESPR 's Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP in Late-Stage Study https://t.co/gl1wffxmpd
March 19th 2019, 6:03am
bulletin_en @bulletin_en
Esperion Therapeutics, Inc. $ESPR Trading at $48.53 after Decline https://t.co/U1WS3aq2fm
March 18th 2019, 4:03pm
reurope_stock @reurope_stock
Esperion Therapeutics, Inc. $ESPR Just Recorded A Sigfniciant Decline https://t.co/eBSfBRXCw9
March 18th 2019, 3:03pm
YuZhu4 @YuZhu4
RT @ByJonGardner: $ESPR and $AMRN bolster cases for approval, but the commercial questions linger. #ACC19 https://t.co/AwcKYL7vXt
March 18th 2019, 3:03pm
ByJonGardner @ByJonGardner
$ESPR and $AMRN bolster cases for approval, but the commercial questions linger. #ACC19 https://t.co/AwcKYL7vXt
March 18th 2019, 12:03pm
dailypoliticaln @dailypoliticaln
Esperion Therapeutics $ESPR Stock Rating Reaffirmed by Chardan Capital https://t.co/nhmpljbudn
March 18th 2019, 10:03am
BioStocks @BioStocks
$ESPR Announces Late-Breaking Presentation of Final Results of Bempedoic Acid Pivotal Phase 3 Study 2 at #ACC19 https://t.co/5OeNYsrQxN
March 18th 2019, 9:03am
matthewherper @matthewherper
New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered https://t.co/msiTbpLQOA $ESPR (paywall) #acc19
March 18th 2019, 9:03am
thefinreviewer @thefinreviewer
The Insider Target Biotech Purchases $2.49 million of Esperion Therapeutics, Inc. $ESPR; 3 Analysts Bullish Walker… https://t.co/U6stxEieWL
March 18th 2019, 6:03am
OlympiaReport @OlympiaReport
Insider Buying: Esperion Therapeutics Inc $ESPR Major Shareholder Buys $2,494,500.00 in Stock https://t.co/OqFboZtzdL
March 18th 2019, 4:03am
BlogYomi @BlogYomi
bluebird bio Inc. $ESPR Comparison side by side https://t.co/EtQ86Z6eF5
March 17th 2019, 11:03pm
stocknewstimes @stocknewstimes
Esperion Therapeutics Inc $ESPR CEO Purchases $243,650.00 in Stock https://t.co/geh7rXXdzx
March 17th 2019, 12:03pm
TranscriptDaily @TranscriptDaily
Esperion Therapeutics Inc $ESPR CEO Purchases $243,650.00 in Stock https://t.co/eOTNiEokP2
March 17th 2019, 12:03pm
bibeypost_stock @bibeypost_stock
Esperion Therapeutics INC Ne $ESPR Holder Partner Fund Management LP Has Lowered Position as Share Price Declined https://t.co/MIrKjoo5TH
March 17th 2019, 9:03am
ConsumerFeed @ConsumerFeed
Esperion Therapeutics $ESPR Upgraded to “Neutral” at JPMorgan Chase & Co. https://t.co/FxADojATfn
March 17th 2019, 8:03am
bbnsnews @bbnsnews
Esperion Therapeutics $ESPR Upgraded to “Neutral” at JPMorgan Chase & Co. https://t.co/CSgPVvO5y7
March 17th 2019, 8:03am
UlmHi @UlmHi
Reviewing CollPlant Holdings Ltd. $ESPR's results https://t.co/NmONBvQ6DE
March 17th 2019, 8:03am
MarketChmln @MarketChmln
$ESPR upcoming event March 18: American College of Cardiology (ACC) Scientific Sessions & Expo. Options expiring on… https://t.co/QvVBvDxX6X
March 17th 2019, 7:03am
bbnsnews @bbnsnews
Target N. V. Biotech Buys 50,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/DT6X4M03dQ
March 17th 2019, 5:03am
TranscriptDaily @TranscriptDaily
Esperion Therapeutics $ESPR Rating Increased to Neutral at JPMorgan Chase & Co. https://t.co/r18mOjP1sB
March 16th 2019, 6:03pm
ZolmaxNews @ZolmaxNews
Roger S. Newton Sells 25,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/duyQZ7TBHi
March 16th 2019, 6:03pm
thefinreviewer @thefinreviewer
Esperion Therapeutics $ESPR Shareholder Sabby Management Has Lifted Its Stake; As https://t.co/MeFVwzGYx1 $AMZN Sto… https://t.co/XSIXdq6hX3
March 16th 2019, 5:03pm
OlympiaReport @OlympiaReport
Esperion Therapeutics Inc $ESPR CEO Purchases $243,650.00 in Stock https://t.co/RybU8Psvw1
March 16th 2019, 4:03pm
WatchlistN @WatchlistN
Insider Buying: Esperion Therapeutics Inc $ESPR Major Shareholder Buys 50,000 Shares of Stock https://t.co/ljvK3gTRgC
March 16th 2019, 2:03pm
registrarjourn @registrarjourn
Esperion Therapeutics $ESPR Given Hold Rating at Chardan Capital https://t.co/walVlj3Udw
March 16th 2019, 5:03am
EnterpriseLeade @EnterpriseLeade
Esperion Therapeutics $ESPR Given Hold Rating at Chardan Capital https://t.co/4tZZgk70HH
March 16th 2019, 5:03am
ThisLincolnian @ThisLincolnian
Esperion Therapeutics $ESPR Trading Down 8.5% After Insider Selling https://t.co/9RC7mDszM4
March 16th 2019, 3:03am
InsiderAlertsIA @InsiderAlertsIA
$ESPR: New Insider Filing on 10%+ Owner BIOTECH TARGET N V: https://t.co/p7CYpXeW7O
March 15th 2019, 8:03pm
TickerReport @TickerReport
Target N. V. Biotech Purchases 50,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/K6PAoWdQvQ
March 15th 2019, 8:03pm
dailypoliticaln @dailypoliticaln
Target N. V. Biotech Buys 50,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/U8qALsLuak
March 15th 2019, 8:03pm
ExecPicks @ExecPicks
Insider alert: Insider BIOTECH TARGET N V of $ESPR bought 50,000 shares @ $2,494,355.00
March 15th 2019, 7:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.